- Home
- CCCS vs BPMC Comparison
CCCS vs BPMC Comparison
Compare CCCS & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCS
- BPMC
- Stock Information
- Founded
- CCCS 1980
- BPMC 2008
- Country
- CCCS United States
- BPMC United States
- Employees
- CCCS N/A
- BPMC N/A
- Industry
- CCCS Computer Software: Prepackaged Software
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- CCCS Technology
- BPMC Health Care
- Exchange
- CCCS Nasdaq
- BPMC Nasdaq
- Market Cap
- CCCS 5.8B
- BPMC 5.8B
- IPO Year
- CCCS N/A
- BPMC 2015
- Fundamental
- Price
- CCCS $9.01
- BPMC $97.17
- Analyst Decision
- CCCS Buy
- BPMC Buy
- Analyst Count
- CCCS 7
- BPMC 21
- Target Price
- CCCS $12.29
- BPMC $124.05
- AVG Volume (30 Days)
- CCCS 6.1M
- BPMC 973.2K
- Earning Date
- CCCS 05-06-2025
- BPMC 05-01-2025
- Dividend Yield
- CCCS N/A
- BPMC N/A
- EPS Growth
- CCCS N/A
- BPMC N/A
- EPS
- CCCS 0.01
- BPMC N/A
- Revenue
- CCCS $969,128,000.00
- BPMC $562,121,000.00
- Revenue This Year
- CCCS $14.10
- BPMC $44.85
- Revenue Next Year
- CCCS $9.28
- BPMC $32.06
- P/E Ratio
- CCCS $706.50
- BPMC N/A
- Revenue Growth
- CCCS 9.05
- BPMC 99.19
- 52 Week Low
- CCCS $8.14
- BPMC $73.04
- 52 Week High
- CCCS $12.88
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- CCCS 50.33
- BPMC 59.54
- Support Level
- CCCS $8.20
- BPMC $87.03
- Resistance Level
- CCCS $9.35
- BPMC $104.86
- Average True Range (ATR)
- CCCS 0.28
- BPMC 3.86
- MACD
- CCCS 0.02
- BPMC 1.24
- Stochastic Oscillator
- CCCS 69.23
- BPMC 64.38
About CCCS CCC Intelligent Solutions Holdings Inc.
CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, and AI-enabled digital workflows. It operates in a single segment being Domestic segment which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in United States and China. Majority of the revenue is generated from United States.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.